SCHEMBL7664253

SCHEMBL7664253

N=C(N)c1ccc(NC(=O)c2ccccc2-c2cccc(C(=O)OCc3ccccc3)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 4/20 0.61
PLAT P00750 4/20 0.61
F10 P00742 8/20 0.57
PRSS1 P07477 5/20 0.57
PRSS2 P07478 4/20 0.57
PRSS3 P35030 4/20 0.57
ROCK2 O75116 1/20 0.57
F2 P00734 5/20 0.48
F7 P08709 1/20 0.48
F3 P13726 1/20 0.48
PLG P00747 2/20 0.48
KLK1 P06870 5/20 0.47
KLK5 Q9Y337 5/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664155 0.92 PLAU (0.58) PLAUPLATF10PRSS1PRSS2
SCHEMBL7659008 0.90 PLAU (0.62) PLAUPLATF10PRSS1PRSS2
SCHEMBL7658212 0.87 PLAU (0.60) PLAUPLATF10PRSS1PRSS2
SCHEMBL7659610 0.84 PLAU (0.69) PLAUPLATF10PRSS1PRSS2
SCHEMBL7656110 0.82 F2 (0.53) PLAUPLATF10PRSS1PRSS2
SCHEMBL7660778 0.82 F2 (0.55) PLAUPLATF10PRSS1PRSS2
SCHEMBL7855281 0.82 PLAU (0.58) PLAUPLATF10PRSS1PRSS2
SCHEMBL7656825 0.82 F10 (0.55) PLAUPLATF10PRSS1PRSS2
SCHEMBL7656816 0.82 F2 (0.58) PLAUPLATF10PRSS1PRSS2
SCHEMBL7657281 0.82 F10 (0.52) PLAUPLATF10PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed